Individual tests

Addis sediment is a semi-urine test used to measure and calculate indicators such as red blood cells, platelets, white blood cells, and urinary casts. This test is important in diagnosing and following up kidney diseases, especially nephrotic syndrome.
AFP is a type of tumor marker produced by cancer cells or normal cells in response to cancer. High levels of AFP can indicate cancer of the liver, ovaries, or testicles. However, other non-cancerous conditions can also increase AFP levels, so this test alone can't fully diagnose cancer.
The aPTT is one of several blood coagulation tests. It measures how long it takes your blood to form a clot. When one of your blood vessels is damaged, proteins called clotting factors come together to form clots and quickly stop the bleeding. The aPTT test helps assess how well those clotting factors work, often in conjunction with other tests that monitor clotting factors.
A blood smear is a sample spread on a glass slide and treated with a special stain. Previously, all blood smears were examined under a microscope by laboratory professionals. Now automated digital systems can help examine blood smears. A blood smear helps diagnose and monitor conditions such as blood disorders, sudden kidney failure, and certain cancer treatments.
This test helps monitor certain cancers during and after treatment and checks for recurrence. It can identify early signs of ovarian cancer in high-risk patients. Some non-cancerous conditions can increase the level of this protein, such as menstruation and uterine fibroids. Certain cancers may also cause an increased level of CA 125, including ovarian, endometrial, peritoneal, and fallopian tube cancers.
If your CA 15-3 results are elevated, additional testing is needed to diagnose breast cancer. If the elevation is minimal, you may need to watch, wait, and order a repeat test 4-6 weeks later. The CA 15-3 elevations in non-cancerous conditions tend to be stable over time. If elevation persists or increases, you may need additional testing, such as breast ultrasound, mammography, or a CT scan
The CA 19.9 quantitative test screens for abnormalities related to the pancreas and bile.
Cancer antigen CA72-4 is a tumor marker found elevated in various human malignant tumors, including ovarian, gastrointestinal (i.e., stomach, colon, and small bowel), and pancreatic cancer. It is used to manage metastatic and recurrent cancer and assess antitumor therapy response.
loading.svg